ASX:IDXHealthcare
Integral Diagnostics (ASX:IDX) Shares Reflect Cash Backed Recovery And Capex Risk
Integral Diagnostics shareholders came into today with the stock grinding higher, up about 10% over three months and closing at A$2.33 on Wednesday. The market has been treating it like a slow repair story. The FY26 numbers tell a sharper tale. Operating net profit after tax reached A$47.4m and operating earnings per share hit A$0.126, while operating free cash flow of A$106.4m backed those profits with cash. The real question for you now is whether today’s calm price reaction reflects...